MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Solas Capital Management Frederick Tucker Golden | 3,030,845 | $3,576,397 | 2% | |
| 2. | 683 Capital Partners Ari Zweiman | 1,066,666 | $1,258,666 | 0.05% | |
| 3. | Renaissance Technologies Jim Simons | 399,100 | $470,938 | -4% | 0% |
| 4. | Alyeska Investment Group Anand Parekh | 295,436 | $348,614 | -89% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 226,877 | $267,715 | +812% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.00 | 18,782 | $18,782.00 | 1,619,178 | 2026-11-16 | Filing | |
| $1.00 | 81,218 | $81,218.00 | 1,600,396 | 2026-11-13 | Filing | |
| $1.00 | 39,600 | $39,600.00 | 1,149,121 | 2026-11-16 | Filing | |
| $1.00 | 60,400 | $60,400.00 | 1,109,521 | 2026-11-13 | Filing | |
| $1.37 | 73,000 | $100,010.00 | 1,049,121 | 2026-09-14 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,413,270 | $2,847,659 | 0% | |
| 2. | 1,167,070 | $1,272,106 | 0.19% | |
| 3. | 584,401 | $689,808 | 0% | |
| 4. | 514,583 | $607,208 | 0.07% | |
| 5. | 500,000 | $590,000 | 0.06% |